RAP 0.00% 20.5¢ resapp health limited

Ann: Medgate Licence Agreement Clarification Announcement, page-31

  1. 394 Posts.
    lightbulb Created with Sketch. 222
    I cannot help laughing when I saw the ann this morning. Investors were about to take the 1.7m wall of .135 after last week's big anns, they got mystified again. What the hell is this RAP share, people are thinking. What a tight ass Pfizer is, we are thinking. If you are new and about to invest RAP, let me run down from the story begin.

    When Pfizer first attracted by RAP Covid Screen tool, they found the amazing tech was run by a bunch of soft butter newbie. BOD only ask 3 or 4 million dollars of investment, and will return covid licence agreement and first negotiation advantage. Not like Sanofi, Medgate or other firm, more hungry Pfizer wanted it exclusively. They worked out other part of RAP worth 200-300m dollars but MC is 50m. Therefore they proposed a plan to BOD, If it succeed, they will get covid screen exclusively, in return BOD will still run the rest of RAP business in the name of Pfizer Australia employee and other unknown entitlement. Newbies mouse watered, what a fantastic career achievement, for an Aussie listed company T/O by Pfizer. If this plan fail, it does not hurt Pfizer at all, they secured 2 x 3 month extension after 6 month R&D, a timeline made for Covid Screen tool to submit its FDA application.

    In his driving seat, Pfizer collected cheap RAP shares and throw out low ball offer #1, price and anns all frozen, till one day in May, HC members started to receive survey calls. On the last day of May, P & B broke his heart learning IER draft report was against them.
    Along with low ball offer #2, Pfizer setup a no fly zone across the country. From all source RAP worth 9cents (anything above that is premium), no potential(little process), and not worth investing at all(no price move). If you happen to have invested RAP, please feel free to make 10% and vote yes.

    It was the first week of July, big P got angry again as Medgate dare to be interested and expand its deal with RAP. One dark night on the weekend, BOD sincerely apologized they forgot to clarify to public Medgate was only flirting without going to the bedroom, Medgate will not generate revenue, as if they have never paid RAP any money. Hence we saw an instant correction ann first thing in the morning. Message to you as investors: stop buying RAP, we have no revenue and won't have revenue, either sell at 13 cents to big P, or hold on until you can make 10%.

    There's a Chinese old saying: deeds proposed by human, but decided by God. Whoever Pfizer is, he is not God.

    PS: I forgot what's the exact date SH first received IE phone call, takes around 2-3 weeks in May to hand in the draft? They can either adjust the draft to say it's not in the best interest of SH again, or wait for the quarterly to finalize. But the way some of us tole them are clear enough, it's time to stop the invader.


 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.